1,371 research outputs found

    Mental support for health care professionals essential during the COVID-19 pandemic:Updates

    Get PDF
    The coronavirus disease 2019 (COVID-19) pandemic continues and concerns regarding its consequences rise. This concern is addressed by other professionals (e.g. the use of a multidisciplinary approach1 or the possible increase in suicidal behaviour).2 However, the continuing huge pressure on mental health care professionals warrants the supporting of their mental health but regretfully, this topic received little attention

    Potential of Organic Rankine Cycles (ORC) for waste heat recovery on an Electric Arc Furnace (EAF)

    Get PDF
    The organic Rankine cycle (ORC) is a mature technology to convert low temperature waste heat to electricity. While several energy intensive industries could benefit from the integration of an ORC, their adoption rate is rather low. One important reason is that the prospective end-users find it difficult to recognize and realise the possible energy savings. In more recent years, the electric arc furnaces (EAF) are considered as a major candidate for waste heat recovery. Therefore, in this work, the integration of an ORC coupled to a 100 MWe EAF is investigated. The effect of working with averaged heat profiles, a steam buffer and optimized ORC architectures is investigated. The results show that it is crucial to take into account the heat profile variations for the typical batch process of an EAF. An optimized subcritical ORC (SCORC) can generate an electricity output of 752 kWe with a steam buffer working at 25 bar. However, the use of a steam buffer also impacts the heat transfer to the ORC. A reduction up to 61.5% in net power output is possible due to the additional isothermal plateau of the steam

    Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver

    Full text link
    The proteasome is critically involved in the production of MHC class I-restricted T cell epitopes. Proteasome activity and epitope production are altered by IFN-gamma treatment, which leads to a gradual replacement of constitutive proteasomes by immunoproteasomes in vitro. However, a quantitative analysis of changes in the steady state subunit composition of proteasomes during an immune response against viruses or bacteria in vivo has not been reported. Here we show that the infection of mice with lymphocytic choriomeningitis virus or Listeria monocytogenes leads to an almost complete replacement of constitutive proteasomes by immunoproteasomes in the liver within 7 days. Proteasome replacements were markedly reduced in IFN-gamma(-/-) mice, but were only slightly affected in IFN-alphaR(-/-) and perforin(-/-) mice. The proteasome regulator PA28alpha/beta was up-regulated, whereas PA28gamma was reduced in the liver of lymphocytic choriomeningitis virus-infected mice. Proteasome replacements in the liver strongly altered proteasome activity and were unexpected to this extent, since an in vivo half-life of 12 days had been previously assigned to constitutive proteasomes in the liver. Our results suggest that during the peak phase of viral and bacterial elimination the antiviral cytotoxic T lymphocyte response is directed mainly to immunoproteasome-dependent T cell epitopes, which would be a novel parameter for the design of vaccines

    Chlamydia control activities in Europe: cross-sectional survey

    Get PDF
    Background: Chlamydia is the most commonly reported bacterial sexually transmitted infection in Europe. The objective of the Screening for Chlamydia in Europe (SCREen) project was to describe current and planned chlamydia control activities in Europe. Methods: The authors sent a questionnaire asking about different aspects of chlamydia epidemiology and control to public health and clinical experts in each country in 2007. The principles of sexually transmitted infection control were used to develop a typology comprising five categories of chlamydia control activities. Each country was assigned to a category, based on responses to the questionnaire. Results: Experts in 29 of 33 (88%) invited countries responded. Thirteen of 29 countries (45%) had no current chlamydia control activities. Six countries in this group stated that there were plans to introduce chlamydia screening programmes. There were five countries (17%) with case management guidelines only. Three countries (10%) also recommended case finding amongst partners of diagnosed chlamydia cases or people with another sexually transmitted infection. Six countries (21%) further specified groups of asymptomatic people eligible for opportunistic chlamydia testing. Two countries (7%) reported a chlamydia screening programme. There was no consistent association between the per capita gross domestic product of a country and the intensity of chlamydia control activities (P = 0.816). Conclusion: A newly developed classification system allowed the breadth of ongoing national chlamydia control activities to be described and categorized. Chlamydia control strategies should ensure that clinical guidelines to optimize chlamydia diagnosis and case management have been implemented before considering the appropriateness of screening programmes
    • 

    corecore